30th Aug 2012 07:00
For immediate release | 30 August 2012 |
ABCAM PLC
("Abcam" or the "Company")
Notification of Preliminary Results
Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, will announce its preliminary results for the year ended 30 June 2012 on Thursday 6 September 2012.
A briefing for analysts will be held at 10.30am on the morning of the results at the offices of Buchanan, 107 Cheapside, London, EC2V 6DN.
For further information, or to register your attendance, please contact Buchanan on 020 7466 5000.
For further information:
Abcam | + 44 (0) 1223 696 000 |
|
Jonathan Milner, Chief Executive Officer |
| |
Jeff Iliffe, Chief Financial Officer |
| |
www.abcam.com www.alliancepharma.co.uk |
| |
Numis Securities - Nominated Adviser & Joint Broker | + 44 (0) 20 7260 1000 |
|
Michael Meade / Nick Westlake - Nominated Adviser |
| |
James Black - Corporate Broking
|
| |
Peel Hunt LLP - Joint Broker | + 44 (0) 207 418 8900 |
|
Andy Crossley - Corporate Broking
|
| |
Buchanan | + 44 (0) 20 7466 5000 |
|
Mark Court / Fiona Henson / Sophie Cowles
| ||
Notes to editors:
About Abcam plc
Abcam is a producer and distributor of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level, which is essential in understanding health and disease.
Headquartered in Cambridge (UK), Abcam has subsidiary offices in Bristol (UK), Cambridge, MA (USA), Eugene, OR (USA), San Francisco, CA (USA), Tokyo (Japan), Hangzhou and Hong Kong (both in China), allowing it to serve a global customer base in over 85 countries. Abcam employs over 600 staff across its eight operating companies.
Abcam now has an online catalogue of over 92,500 products sourced from over 300 suppliers. The catalogue includes a growing range of non-primary antibody products such as secondaries, proteins, peptides, lysates, immunoassays and other kits. Products are available for life science research and distributed to academic and commercial users. A highly developed eCommerce platform, which includes regional websites for the Chinese and Japanese markets, allows customers to access up-to-date and detailed technical product data sheets at the Company's website www.abcam.com.
Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company's vision is to be the world's leading life science tools company.
Related Shares:
ABC.L